Exact Sciences rolls out Cancerguard multi-cancer blood test
Exact Sciences has launched its long-awaited blood test designed to detect the early stages of multiple tumors, with a plan to sell it to consumers through a telehealth program in…
GE HealthCare to acquire brain MRI software developer icometrix
GE HealthCare aims to further build out its portfolio of programs focused on brain scans with a deal to acquire the MRI artificial intelligence developer icometrix following years of collaborating.…
Apple aims to catch 1 million hypertension cases in one year with new Apple Watch
Apple’s latest smartwatch—as well as some previous models—will soon carry the ability to detect potentially high blood pressure, the top risk factor for cardiovascular disease. Making its debut alongside the…
The invisible plastic threat you can finally see
A joint team from the University of Stuttgart in Germany and the University of Melbourne in Australia has developed a new method for the straightforward analysis of tiny nanoplastic particles…
Ronovo Surgical raises $67M for modular laparoscopic robot with J&J backing
The Chinese minimally invasive robot developer Ronovo Surgical announced it has raised $67 million to expand the commercial reach of its system within the country, with a helping hand from…
OraSure comes under investor pressure, with potential proxy fight: report
Infectious disease testmaker OraSure Technologies is coming under additional pressure from investors, according to reports—with a potential fight brewing over its board of directors, following the rejection of a buyout…
Microbot Medical scores FDA clearance for remote-controlled cath lab system
Microbot Medical has received the FDA’s blessing for its miniature, remote-controlled robot for endovascular procedures, designed to offer clinicians the freedom to sit comfortably and operate outside the cath lab’s…
Senseonics to retake Eversense CGM commercial control from Ascensia Diabetes Care
Senseonics plans to take back full commercial control of its Eversense continuous glucose monitoring platforms from its distribution partner Ascensia Diabetes Care, as it aims to speed up the rollout…
Medtronic’s Hugo robot logs success in hernia repair trial
While its Hugo surgical robot undergoes review at the FDA, Medtronic presented clinical data from its U.S. trial demonstrating success in hernia repairs—notably with zero mid-procedure conversions to traditional surgical…
Galvanize Therapeutics nets $100M, and a new CEO, to bring pulsed field ablation to lung cancer
Galvanize Therapeutics has raised $100 million in venture capital backing—and is making a change in leadership—to help energize its development of pulsed field ablation technology for use against cancer and…